Valuation: Nexien BioPharma, Inc. ; P/E ratio · EV / Sales · Yield *. Nexien BioPharma Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Find the latest Nexien BioPharma Inc (NXEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Get Nexien Biopharma Inc (NXEN-FF:OTCPK) real-time stock quotes, news, price and financial information from CNBC. Get the latest Nexien Biopharma Inc (NXEN) real-time quote, historical performance, charts, and other financial information to help you make more informed.
Research Nexien BioPharma's (OTCPK:NXEN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. View NEXIEN BIOPHARMA INC (NXEN) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. NXEN | Complete Nexien BioPharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nexien BioPharma's stock was trading at $ on January 1st, Since then, NXEN shares have decreased by % and is now trading at $ View the. Nexien Biopharma Revenue, EBIT and net profit per share ; , 0 undefined, M undefined ; , 0 undefined, M undefined ; , 0 undefined, M. View the latest Nexien BioPharma Inc. (NXEN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover real-time Nexien BioPharma Inc (NXEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades. (NXEN) ROE by Quarter and Year. Discovering the peaks and valleys of Nexien BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights. NXEN Nexien Biopharma Inc. $ $ (%). Today. Watchers, Wk Low, $ Wk High, $ Market Cap, $M. Volume, 16, Nexien BioPharma Inc. options quotes data for sells and puts, including NXEN last price, change and volume.
Nexien BioPharma Inc Research and Development of Cannabinoid Pharmaceuticals in Accordance with United States Food and Drug Administration (FDA) Regulatory. Key Stats · Market CapM · Shares OutM · 10 Day Average Volume12, · Dividend- · Dividend Yield- · Beta · YTD % Change Stock analysis for Nexien BioPharma Inc (NXEN:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nexien BioPharma Stock (OTC: NXEN) stock price, news, charts, stock research, profile. Nexien BioPharma Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. At present, our Common Stock is subject to quotation on the OTCQB under the symbol "NXEN". There is only a limited and non-liquid public trading market for our. Find the latest Nexien BioPharma, Inc. (NTVA) stock quote, history, news and other vital information to help you with your stock trading and investing. NXEN · Nexien BioPharma, Inc. Common Stock. %. Overall, Nexien Biopharma Inc stock has a Growth Grade of F, Momentum Grade of C. Whether or not you should buy Nexien Biopharma Inc stock will ultimately.
NXEN - Nexien BioPharma, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (OTCPK) ; Owners. Institutional Owners Retail Ownership ; Short. Get Nexien Biopharma Inc (achaki.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Description. Nexien BioPharma Inc is a researcher and developer of cannabinoid-based pharmaceutical for various medical conditions and disorders, all under U.S. Other Pharmaceuticals ; NEXIEN BIOPHARMA, INC. Stock Nexien BioPharma, Inc. %, % ; ELI LILLY AND COMPANY · Stock Eli Lilly and Company. +%, %. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding.
Nexien in the News · August 27, European Pharmaceutical Review Cannabinoids in pharma series: the future prospects of cannabinoids · August 15,